The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer
Open accessAbstract
BACKGROUND: Lung cancer is the largest contributor to mortality from cancer. The National Lung Screening Trial (NLST) showed that screening with low-dose helical computed tomography (CT) rather than with chest radiography reduced mortality from lung cancer. We describe the screening, diagnosis, and limited treatment results from the initial round of screening in the NLST to inform and improve lung-cancer-screening programs. METHODS: At 33 U.S. centers, from August 2002 through April 2004, we enrolled asymptomatic participants, 55 to 74 years of age, with a history of at least 30 pack-years of smoking. The participants were randomly assigned to undergo annual screening, with the use of either low-dose CT or chest radiography, for 3 years. Nodules or other suspicious findings were classified as positive results. This article reports findings from the initial screening examination. RESULTS: A total of 53,439 eligible participants were randomly assigned to a study group (26,715 to low-dose CT and 26,724 to chest radiography); 26,309 participants (98.5%) and 26,035 (97.4%), respectively, underwent screening. A total of 7191 participants (27.3%) in the low-dose CT group and 2387 (9.2%) in the radiography group had a positive screening result; in the respective groups, 6369 participants (90.4%) and 2176 (92.7%) had at least one follow-up diagnostic procedure, including imaging in 5717 (81.1%) and 2010 (85.6%) and surgery in 297 (4.2%) and 121 (5.2%). Lung cancer was diagnosed in 292 participants (1.1%) in the low-dose CT group versus 190 (0.7%) in the radiography group (stage 1 in 158 vs. 70 participants and stage IIB to IV in 120 vs. 112). Sensitivity and specificity were 93.8% and 73.4% for low-dose CT and 73.5% and 91.3% for chest radiography, respectively. CONCLUSIONS: The NLST initial screening results are consistent with the existing literature on screening by means of low-dose CT and chest radiography, suggesting that a reduction in mortality from lung cancer is achievable at U.S. screening centers that have staff experienced in chest CT. (Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Self-citationChild abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cited by
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965
Callister, M. E. J., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., Graham, R., Malhotra, P., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207168 · Cited by 958
Ageing and the epidemiology of multimorbidity
Divo, M. J., Martinez, C. H., & Mannino, D. M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00059814 · Cited by 701
Integrating genomic features for non-invasive early lung cancer detection
Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., Schroers-Martin, J., Nabet, B. Y., Chen, B., Chaudhuri, A. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2140-0 · Cited by 685
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 633
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0020 · Cited by 611
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
Cohen, E. E. W., LaMonte, S. J., Erb, N. L., Beckman, K. L., Sadeghi, N., Hutcheson, K. A., Stubblefield, M. D., Abbott, D. M., Fisher, P. S., Stein, K. D., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21343 · Cited by 608
Results of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 550
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
Black, W. C., Gareen, I. F., Soneji, S. S., Sicks, J. D., Keeler, E. B., Aberle, D. R., Naeim, A., Church, T. R., Silvestri, G. A., Gorelick, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312547 · Cited by 544
Humphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Horeweg, N., van Rosmalen, J., Heuvelmans, M. A., van der Aalst, C. M., Vliegenthart, R., Scholten, E. T., ten Haaf, K., Nackaerts, K., Lammers, J.-W. J., Weenink, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70389-4 · Cited by 526
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00432-6 · Cited by 519
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment
Pinsky, P. F., Gierada, D. S., Black, W., Munden, R., Nath, H., Aberle, D., & Kazerooni, E. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2086 · Cited by 508
Evaluating the Patient With a Pulmonary Nodule: A Review
Mazzone, P. J., & Lam, L. (2022) · JAMA · doi:10.1001/jama.2021.24287 · Cited by 487
Epidemiology of lung cancer in China
Cao, M., & Chen, W. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12916 · Cited by 471
Adams, S. J., Stone, E., Baldwin, D. R., Vliegenthart, R., Lee, P., & Fintelmann, F. J. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01694-4 · Cited by 467
Patel, J. D., Krilov, L., Adams, S., Aghajanian, C., Basch, E., Brose, M. S., Carroll, W. L., de Lima, M., Gilbert, M. R., Kris, M. G., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.7076 · Cited by 434
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
Schrag, D., Beer, T. M., McDonnell, C. H., Nadauld, L., Dilaveri, C. A., Reid, R., Marinac, C. R., Chung, K. C., Lopatin, M., Fung, E. T., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01700-2 · Cited by 396
Horeweg, N., Scholten, E. T., de Jong, P. A., van der Aalst, C. M., Weenink, C., Lammers, J.-W. J., Nackaerts, K., Vliegenthart, R., ten Haaf, K., Yousaf-Khan, U. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70387-0 · Cited by 384
First trimester preeclampsia screening and prediction
Chaemsaithong, P., Sahota, D. S., & Poon, L. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.020 · Cited by 363
Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Soo Hoo, G., & Detterbeck, F. C. (2018) · Chest · doi:10.1016/j.chest.2018.01.016 · Cited by 348
Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O., & Francoz, C. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.009 · Cited by 320
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., et al. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 310
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
Motzer, R. J., Jonasch, E., Michaelson, M. D., Nandagopal, L., Gore, J. L., George, S., Alva, A., Haas, N., Harrison, M. R., Plimack, E. R., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0054 · Cited by 287
Lung cancer epigenetics: From knowledge to applications
Duruisseaux, M., & Esteller, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.09.005 · Cited by 283
Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis
Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.11.003 · Cited by 263
Mazzone, P. J., Silvestri, G. A., Souter, L. H., Caverly, T. J., Kanne, J. P., Katki, H. A., Wiener, R. S., & Detterbeck, F. C. (2021) · Chest · doi:10.1016/j.chest.2021.06.063 · Cited by 254
Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath
Shehada, N., Cancilla, J. C., Torrecilla, J. S., Pariente, E. S., Brönstrup, G., Christiansen, S., Johnson, D. W., Leja, M., Davies, M. P. A., Liran, O., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b03127 · Cited by 227
Role of imaging in the era of precision medicine
Giardino, A., Gupta, S., Olson, E., Sepulveda, K., Lenchik, L., Ivanidze, J., Rakow-Penner, R., Patel, M. J., Subramaniam, R. M., & Ganeshan, D. (2017) · Academic Radiology · doi:10.1016/j.acra.2016.11.021 · Cited by 87
Chari, S. T., Maitra, A., Matrisian, L. M., Shrader, E. E., Wu, B. U., Kambadakone, A., Zhao, Y.-Q., Kenner, B., Rinaudo, J. A. S., Srivastava, S., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106659 · Cited by 62
Performance of Deep Learning Model in Detecting Operable Lung Cancer With Chest Radiographs
Cha, M. J., Chung, M. J., Lee, J. H., & Lee, K. S. (2019) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000388 · Cited by 56
Machine Learning Applications in Lung Cancer Diagnosis, Treatment and Prognosis
Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022) · arXiv · doi:10.48550/arxiv.2203.02794 · Cited by 2
Metadata
- Authors
- The National Lung Screening Trial Research Team
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-05-23
- Volume
- 368
- Issue
- 21
- Pages
- 1980-1991
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2121203541
- Cited by
- 1,088
- References
- 32
- FWCI
- 66.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.